AstraZeneca inks U.S. co-commercialization deal for OIC med
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 11:14AM CDT
AZN: 69.29 (-0.81), NKTR: 11.13 (+0.20)
FDA clears Daiichi-Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 6:55PM CST
PTLA: 37.21 (-0.35), PFE: 33.99 (+0.05), BMY: 67.64 (+0.19), JNJ: 102.30 (+0.47), ISIS: 62.55 (+0.10), MDCO: 26.35 (+0.35), BAX: 69.36 (+0.32), AZN: 69.29 (-0.81), MRK: 60.23 (+0.45), SCLN: 9.34 (+0.21), MSLI: 2.42 (-0.01)
ArQule prostate cancer drug candidate successful in Phase 2
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:19AM CST
ARQL: 1.87 (+0.06)
Ad Comm approaches for Daiichi Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:49PM CDT
The Next Biotech Buyout Stock
Motley Fool Staff - Motley Fool - Fri Oct 10, 7:15AM CDT
Biotech stocks are notoriously volatile, making them best suited for only the most risk-tolerant investors. But for those willing to take the risk, biotech companies can often make a big splash; particularly when a bigger fish gobbles them up....
JNJ: 102.30 (+0.47), PTLA: 37.21 (-0.35), PFE: 33.99 (+0.05), BMY: 67.64 (+0.19), PRTA: 30.99 (-0.85), PBYI: 177.01 (+6.34)